Literature DB >> 35870093

The effect of sex differences on complications and 90-day outcomes after aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis.

Runting Li1, Fa Lin1, Yu Chen1, Junlin Lu1, Jun Yang1, Heze Han1, Kexin Yuan1, Ke Wang1, Debin Yan1, Ruinan Li1, Shihao He1, Zhipeng Li1, Haibin Zhang1, Xiheng Chen2, Li Ma1, Yahui Zhao1, Qiang Hao1, Xun Ye1, Hao Wang1, Hongliang Li3, Linlin Zhang3, Guangzhi Shi3, Jianxin Zhou3, Youxiang Li2, Shuo Wang1,4,5,6, Xiaolin Chen7,8,9, Yuanli Zhao10,11,12,13.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is the most devastating form of stroke. Up to now, little is known about the effect of sex differences on complications and outcomes. We retrospectively reviewed aSAH patients admitted to our institution between January 2015 and December 2020. The functional outcomes at discharge and 90 days after discharge were assessed using the modified Rankin Scale (mRS). Baseline characteristics, in-hospital complications, and outcomes were compared after 1:1 propensity score matching (PSM). The area under the curve (AUC) in the receiver operating characteristic curve (ROC) analysis was calculated to measure each independent risk factor's prediction ability. A total of 833 patients were included. After PSM, 109 male patients were compared with 109 female patients. Female patients had a higher incidence of anemia (47/109 [43.1%] vs. 30/109 [27.5%], p = 0.016) than male patients, while male patients had a higher incidence of pneumonia (36/109 [33.0%] vs. 19/109 [17.4%], p = 0.008) than female patients. No significant differences were found in the rate of unfavorable outcomes at discharge and 90-day outcomes (40/109 [36.7%] vs. 50/109 [45.9%], p = 0.169; 15/109 [13.8%] vs. 19/107 [17.8%], p = 0.420) between female and male patients. Pneumonia (AUC = 0.749, 95% confidence interval [CI] = 0.623-0.875, p < 0.001) and anemia (AUC = 0.753, 95% CI = 0.632-0.873, p = 0.002) showed good ability to predict 90-day unfavorable outcomes in male and female patients, respectively. Female patients had a higher incidence of anemia but a lower incidence of pneumonia during hospitalization. However, differences in in-hospital complications did not result in differences in outcomes between women and men. Clinical Trial Registration: NCT04785976. 2021/03/05, retrospectively registered.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aneurysmal subarachnoid hemorrhage; Complication; Outcome; Sex

Mesh:

Year:  2022        PMID: 35870093     DOI: 10.1007/s10143-022-01836-x

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  26 in total

1.  Sex differences in aneurysmal subarachnoid haemorrhage (aSAH): aneurysm characteristics, neurological complications, and outcome.

Authors:  Sabah Rehman; Ronil V Chandra; Kevin Zhou; Darius Tan; Leon Lai; Hamed Asadi; Jens Froelich; Nova Thani; Linda Nichols; Leigh Blizzard; Karen Smith; Amanda G Thrift; Christine Stirling; Michele L Callisaya; Monique Breslin; Mathew J Reeves; Seana Gall
Journal:  Acta Neurochir (Wien)       Date:  2020-06-30       Impact factor: 2.216

2.  Socioeconomic Disadvantage Is Associated with a Higher Incidence of Aneurysmal Subarachnoid Hemorrhage.

Authors:  Linda Nichols; Christine Stirling; Petr Otahal; Jim Stankovich; Seana Gall
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-11-06       Impact factor: 2.136

Review 3.  Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review.

Authors:  C E Lovelock; G J E Rinkel; P M Rothwell
Journal:  Neurology       Date:  2010-04-07       Impact factor: 9.910

4.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

Review 5.  Sex Differences in Cerebral Aneurysms and Subarachnoid Hemorrhage.

Authors:  Angelica M Fuentes; Laura Stone McGuire; Sepideh Amin-Hanjani
Journal:  Stroke       Date:  2022-01-05       Impact factor: 7.914

Review 6.  Endogenous Neural Stem Cell-induced Neurogenesis after Ischemic Stroke: Processes for Brain Repair and Perspectives.

Authors:  Hailiang Tang; Yao Li; Weijun Tang; Jianhong Zhu; Graham C Parker; John H Zhang
Journal:  Transl Stroke Res       Date:  2022-09-03       Impact factor: 6.800

7.  A higher aneurysmal subarachnoid hemorrhage incidence in women prior to menopause: a retrospective analysis of 4,895 cases from eight hospitals in China.

Authors:  Yì Xiáng J Wáng; Jian He; Lihong Zhang; Yao Li; Lin Zhao; Heng Liu; Lin Yang; Xian Jun Zeng; Jian Yang; Guang Ming Peng; Anil Ahuja; Zheng Han Yang
Journal:  Quant Imaging Med Surg       Date:  2016-04

8.  Subarachnoid hemorrhage and the female sex: analysis of risk factors, aneurysm characteristics, and outcomes.

Authors:  Alhafidz Hamdan; Jonathan Barnes; Patrick Mitchell
Journal:  J Neurosurg       Date:  2014-09-12       Impact factor: 5.115

9.  Sex-Related Differences in Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Jesse J Duijghuisen; Paut Greebe; Dennis J Nieuwkamp; Ale Algra; Gabriël J E Rinkel
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-01       Impact factor: 2.136

10.  Gender-related differences in aneurysmal subarachnoid hemorrhage.

Authors:  G L Kongable; G Lanzino; T P Germanson; L L Truskowski; W M Alves; J C Torner; N F Kassell
Journal:  J Neurosurg       Date:  1996-01       Impact factor: 5.115

View more
  1 in total

Review 1.  [Optic nerve decompression-state of the art].

Authors:  Philippe Korn; Jörg Schipper; Philipp Jehn; Nils-Claudius Gellrich
Journal:  HNO       Date:  2022-08-18       Impact factor: 1.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.